Why the UK approved Pfizer-BioNTech COVID-19 vaccine before the US?

Rather than accepting the findings of vaccine makers, U.S. regulators painstakingly reanalyze raw data from the trials to validate the results, poring over what regulators have described as thousands of pages of documents. Regulators in Britain and elsewhere in Europe lean more heavily on companies’ own analyses.

from International-News-Economic Times https://ift.tt/39B1qwk
via IFTTT

SHARE